A randomized trial published in JAMA concluded that there was no statistically significant difference in patient-reported quality of life for atrial-fibrillation (AF) patients with heart failure symptoms who took digoxin versus the beta-blocker bisoprolol (Zebeta).  Digoxin was once widely used for heart failure but has become less popular after a 2015 study found patients who took the drug…